Discovery and optimization of p38 inhibitors via computer-assisted drug design

Integration of computational methods, X-ray crystallography, and structure−activity relationships will be disclosed, which lead to a new class of p38 inhibitors that bind to p38 MAP kinase in a Phe out conformation.